|
Aug 15
|
European Equities Traded in the US as American Depositary Receipts Edge Lower in Friday Trading
|
|
Aug 14
|
European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading
|
|
Aug 13
|
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
|
|
Aug 12
|
Analysts Are Updating Their Silence Therapeutics plc (NASDAQ:SLN) Estimates After Its Second-Quarter Results
|
|
Aug 11
|
European Equities Traded in the US as American Depositary Receipts Begin Week Lower in Monday Trading
|
|
Jul 25
|
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading; Gain 1.6% for Week
|
|
Jul 21
|
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading
|
|
Jul 18
|
European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading
|
|
Jul 17
|
European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading
|
|
Jul 16
|
European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading
|
|
Jul 15
|
European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading
|
|
Jun 27
|
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading; Up 2.5% for Week
|
|
Jun 24
|
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
|
|
Jun 17
|
European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading
|
|
Aug 27
|
Silence Therapeutics to Webcast Presentations at Upcoming September Investor Conferences
|
|
Jun 27
|
Silence Therapeutics Announces Positive Results from Ongoing SANRECO Phase 1 Study of Divesiran in Polycythemia Vera Patients
|
|
Jun 24
|
Silence Therapeutics Achieves $2 Million Research Milestone Payment from Hansoh Pharma Collaboration
|
|
Jun 20
|
Silence Therapeutics Announces Positive Topline 48-Week Data from Phase 2 Study of Zerlasiran in Patients with Elevated Lipoprotein(a)
|
|
Feb 28
|
Silence Therapeutics PLC Sponsored ADR (SLN) Soars 6.4%: Is Further Upside Left in the Stock?
|
|
Feb 28
|
Silence Therapeutics to Report Fourth Quarter and Full Year 2023 Results on March 13, 2024
|